Research Private Equity: Top Firms in 2026

Key Facts

• Global PE assets under management (AUM) total approximately $3 trillion, with pension funds, endowments, sovereign wealth funds, and family offices as the primary limited partners (LPs).
• Uncommitted capital (dry powder) in PE and VC markets sits at a record high of nearly $4 trillion as of 2024, with significant deployment potential despite subdued fundraising activity.
• Deal value fell 60% from the 2021 peak and deal count dropped 35% over the same period, before both investment and exit value began recovering in 2024 as interest rates declined.
• New York, San Francisco, London, Boston, and Chicago anchor global PE and VC activity, with Stockholm and Luxembourg growing as European alternatives hubs.
• LP distributions as a share of net asset value (NAV) reached their lowest rate in over a decade in 2024, pushing general partners toward GP-led secondaries and continuation vehicles.
• AI-driven software, healthcare services, life sciences, and energy infrastructure represent the highest-conviction capital deployment sectors heading into 2026.
• Blackstone leads all PE managers globally at $1 trillion in AUM, followed by Apollo Global Management ($840 billion) and The Carlyle Group ($420 billion).

The Global PE/VC Landscape

Private equity and venture capital firms operate across two distinct strategies within the alternatives market. Private equity covers ownership stakes in non-publicly traded entities, with general partners (GPs) deploying capital through leveraged buyouts (LBOs), growth equity investments, carve-outs from larger corporations, and distressed situations.

Venture capital, a distinct subset, channels early-stage capital into startups and high-growth businesses in exchange for equity. Both strategies feature illiquidity, complexity, and return potential exceeding public market benchmarks.

New York concentrates the largest share of US PE capital, housing Blackstone, Apollo Global Management, KKR, and Tiger Global Management. San Francisco and Menlo Park anchor venture capital through Sequoia Capital and Andreessen Horowitz, while Chicago hosts Thoma Bravo.

In Europe, Stockholm has emerged as a major technology buyout hub through EQT Partners, and Luxembourg serves as the domicile of CVC Capital Partners. Delaware remains the standard legal domicile for US PE fund formation under the Delaware Revised Uniform Limited Partnership Act (DRULPA).

The global market recorded a partial recovery in 2024 after a two-year contraction. Both deal investment and exit value increased year-over-year as inflation declined and interest rates stabilized, though fundraising lagged as a trailing indicator of deal activity. Public pension data shows a median annualized 10-year return of 15.2% for PE funds, a figure that sustains institutional capital demand despite the liquidity constraints facing LPs.

Private Equity and Venture Capital: Firm Comparison

The firms below represent the primary PE and VC managers with verified data, covering the full spectrum from mega-fund diversified buyouts to specialist software investors and venture-stage backers. Firms are sorted by AUM where data is available.

The top three buyout firms by AUM (Blackstone, Apollo, Carlyle) collectively manage over $2.2 trillion, representing the clearest concentration of PE capital in the market. Thoma Bravo's ~$200 billion software-only mandate makes it the largest single-strategy specialist among all PE firms. Sequoia and Andreessen Horowitz combine for over $108 billion in venture AUM, the two largest dedicated VC platforms globally.

Top Picks by Investment Strategy

• Largest AUM Globally: Blackstone at $1 trillion, spanning private equity, real estate, credit, and hedge fund strategies with more than 85 portfolio companies across multiple continents.
• Distressed and Credit Leader: Apollo Global Management at $840 billion, managing the deepest yield-oriented credit platform among global alternative asset managers.
• Software Buyout Specialist: Thoma Bravo at ~$200 billion, whose Boeing digital aviation carve-out demonstrates willingness to separate embedded software value from large industrial conglomerates.
• Strongest European Buyout Platform: CVC Capital Partners at $180–230 billion, the largest European private equity firm by AUM with diversified sector exposure across consumer, financial services, and healthcare.
• Top Mid-Market Track Record: Partners Group at $170 billion-plus, whose sponsorship of the KinderCare Learning Centers IPO (the third-largest US IPO of Q4 2024) demonstrates consistent large-scale exit execution.
• Most Operationally Engaged GP: EQT Partners at ~$120 billion, embedding operating partners and industrial advisors inside every portfolio company from the first 100 days of ownership.
• Venture Capital Franchise by Portfolio Outcomes: Sequoia Capital at $55.7 billion, the firm behind Apple, Google, WhatsApp, Zoom, and PayPal.
• Most Distinctive Life Sciences Research Financier: İş Private Equity, the Turkish firm that committed $39 million to the Gökhan Hotamışlıgil Laboratory at Harvard T.H. Chan School of Public Health and Enlila Biotech in 2025, pioneering direct academic-to-commercial biotech financing.

Top Fund Managers Profiled

Blackstone

Blackstone manages $1 trillion across private equity, real estate, credit, and hedge fund strategies with more than 85 portfolio companies operating worldwide. Its scale generates a competitive moat few fund managers can replicate: access to deal opportunities, co-investment structures, and financing terms unavailable to smaller platforms.

The firm's multi-asset architecture allows LPs to gain diversified alternatives exposure through a single GP relationship. For institutional investors building core alternatives allocations, Blackstone is typically the starting point rather than one option among many.

Apollo Global Management

Apollo's defining structural advantage is the integration of its credit and equity platforms under one management entity. Managing $840 billion as of Q2 2025, the firm operates one of the largest yield-oriented credit platforms in the world alongside its buyout and distressed equity strategies.

That dual capability gives Apollo a structural edge in leveraged buyout financing: it can provide both the debt stack and equity simultaneously, compressing transaction timelines and deal costs. Insurance companies and pension funds with income mandates find Apollo's combined credit-equity offering among the most efficient structures available in the alternatives market.

The Carlyle Group

Geographic reach is Carlyle's primary competitive differentiator. The firm deploys $420 billion across more than 30 countries through private equity, real assets, and global credit mandates, giving it a footprint that US-centric competitors cannot match.

Its Washington D.C. base has provided decades of proximity to defense and government contracting deal flow, producing a consistent pipeline of defense-adjacent carve-outs. LPs seeking diversified buyout exposure across North America, Europe, and Asia often use Carlyle as a core allocation within broader alternatives portfolios.

Thoma Bravo

Mission-critical enterprise software is the only sector Thoma Bravo targets, and that single-strategy discipline at approximately $200 billion AUM is its primary competitive advantage. Deal teams have executed the software buyout playbook dozens of times, building an institutional knowledge base in SaaS metrics, go-to-market efficiency, and margin improvement that generalist competitors cannot replicate.

The Boeing digital aviation carve-out demonstrated the firm's expertise in separating embedded software value from large industrial conglomerates. Software founders evaluating a PE exit should benchmark every competing offer against Thoma Bravo's standard deal terms and post-close operational support model.

Partners Group

Partners Group's sponsorship of the KinderCare Learning Centers IPO on the NYSE in Q4 2024 (the third-largest US IPO of that year) stands as the clearest demonstration of its mid-market exit capabilities. The Zug-based firm manages more than $170 billion across private equity, private debt, infrastructure, and real estate, with active positions in energy transition and digital infrastructure assets.

Its multi-asset structure enables investment across the full capital stack of a single company, creating co-investment opportunities for LPs seeking integrated exposure. Partners Group's realized exit track record places it above most mid-market alternatives managers operating outside the US mega-fund tier.

EQT Partners

Operator depth is EQT Partners' competitive edge. The Stockholm-based firm manages approximately $120 billion through control and co-control investment strategies targeting technology, healthcare, and business services companies across mid and large-cap markets.

EQT deploys dedicated industrial advisors and operating partners embedded within portfolio companies from day one, driving EBITDA improvement at a pace that passive-ownership strategies cannot match. European technology and healthcare businesses seeking an active operational buyer consistently rank EQT among their preferred counterparties.

Sequoia Capital

Sequoia's portfolio history is the strongest proof point in the venture capital industry. Apple, Google, Instagram, PayPal, WhatsApp, and Zoom appear among its realized investments, representing trillions of dollars in aggregate public market value.

Managing $55.7 billion from its Menlo Park base, the firm invests from seed through growth stage in technology companies across the US, Europe, India, and Southeast Asia. For founders raising their first institutional round, a Sequoia commitment accelerates subsequent fundraising on terms that alternative backers typically cannot match.

Andreessen Horowitz (a16z)

Andreessen Horowitz invented the platform model for venture capital, embedding recruiters, marketing specialists, legal advisors, and network brokers within the investment relationship rather than limiting support to capital and board seats. Its $52.7 billion platform backs consumer, enterprise, crypto, bio, and fintech companies from seed through late stage, with Facebook, Airbnb, Lyft, Reddit, and Roblox among its highest-profile portfolio outcomes.

The platform model operates a16z as a portfolio services firm alongside its financial investor function. Founders building category-creating products who want structured institutional support beyond capital should evaluate a16z's operational infrastructure as a primary criterion, not just its check size.

Investment Themes Driving Capital Allocation

AI as a Portfolio Value Creation Lever

Generative AI has shifted from a portfolio company attribute to a fund-level operating priority for PE general partners. Buyout firms are embedding AI efficiency tools into portfolio company operations to improve margin profiles, reduce headcount requirements, and accelerate product development cycles. Thoma Bravo and EQT have both incorporated AI implementation reviews into their standard post-acquisition 100-day operational plans.

Software Margin Improvement as the Core Buyout Thesis

Revenue growth and multiple expansion no longer drive software buyout returns as reliably as in prior cycles. PE fund managers now prioritize EBITDA margin improvement as the central value creation thesis, focusing on cost structure optimization and go-to-market rationalization within existing holdings. That shift favors management teams with operational discipline over pure growth track records when investment committees evaluate acquisition targets.

Healthcare and Life Sciences Consolidation

Healthcare services and life sciences represent the two most active consolidation sectors in current PE deal sourcing, driven by aging demographics, fragmented provider markets, and federal research funding reductions. Buy-and-build strategies assembling regional healthcare providers into national platforms remain a dominant playbook for mid-market fund managers. İş Private Equity's $39 million commitment to the Harvard T.H. Chan School of Public Health laboratory in 2025 signals a distinct model: direct financing of research-stage life sciences assets before commercial viability is established.

GP-Led Secondaries as a Liquidity Management Tool

With LP distributions as a share of NAV at decade-low levels, general partners are constructing GP-led secondaries and continuation vehicles to provide liquidity without forcing exits at depressed valuations. These structures allow GPs to retain high-quality assets beyond the original fund life while offering existing LPs the option to cash out or roll into the new vehicle at a market-clearing price. Dedicated secondary specialists are well-positioned to benefit as GP-led transaction volume continues growing.

Sovereign Wealth and Private Wealth Expansion of the LP Base

The LP base for PE and VC is broadening beyond traditional public pension plans and university endowments. Sovereign wealth funds are expanding direct commitments to established GPs, while private wealth channels are gaining access through feeder funds and interval fund structures. This diversification reduces GP fundraising dependence on institutional LPs who face their own distribution constraints in the current low-NAV-distribution environment.

How to Evaluate PE and VC Fund Managers

Track record is the most defensible starting point. Internal rate of return (IRR) and multiple on invested capital (MOIC) across at least two full fund vintages reveal whether a GP's performance is replicable or a single-cycle outlier. A median annualized 10-year IRR above 15% places a manager in the upper quartile of the industry; consistency across vintages matters more than peak performance in any single fund.

Sector expertise determines whether the firm's deal team will add genuine value or simply manage a balance sheet. A specialist like Thoma Bravo will execute a software buyout with institutional depth unavailable to a generalist competitor, because Thoma Bravo's investment committee has run the identical playbook dozens of times. Match the firm's documented sector concentration to the investment exposure you are seeking rather than relying on stated flexibility.

Fund size and deal size alignment reveals whether your company or investment will receive genuine senior partner attention. A fund managing $15 billion will not dedicate investment committee bandwidth to a $25 million EBITDA target; that position represents less than 0.5% of deployed capital. Target firms whose standard deal sizes fall within two to ten times the company's annual earnings before interest, taxes, depreciation, and amortization (EBITDA).

Fee structure and carried interest terms expose LP-GP alignment. The industry standard charges a 2% management fee on committed capital and a 20% carried interest (performance fee). Carry is paid only after LPs recover their capital plus an 8% annualized hurdle return.

LPs receive 80% of exit profits and the GP takes 20%. Funds where management fees substantially exceed carry as the GP's primary revenue source signal a fee-driven rather than performance-driven business model.

Which PE Firm Fits Your Needs?

Technology founders raising growth capital above $50 million should prioritize Andreessen Horowitz and General Catalyst, both of which combine minority equity structures with dedicated operational support across recruiting, go-to-market, and network access. Enterprise software founders evaluating a full buyout should engage Thoma Bravo as the primary benchmark, given its sector depth and willingness to pay premium valuations for high-retention SaaS businesses. Earlier-stage technology companies raising from seed through growth stage consistently find Sequoia and Accel among the most competitive term sheet providers, given the firms' portfolio signal value and global distribution networks.

LPs constructing diversified alternatives allocations can treat Blackstone, Apollo, and Carlyle as core positions, drawing on their multi-strategy scale and demonstrated liquidity management capabilities. Partners Group and EQT Partners offer differentiated mid-market and European buyout exposure for LPs seeking strong realized returns outside the US mega-fund tier. Institutional investors focused on life sciences and academic biotech should note İş Private Equity's research financing model as a distinctive approach to early-stage exposure before commercial viability is established.

M&A advisors and deal teams building buyer lists for competitive sale processes can use the comparison table above as an initial screening tool. Matching a target company's sector, EBITDA range, and geography to each firm's strategy and fund size narrows outreach lists to the most motivated counterparties. Secondary market participants seeking to sell LP interests or acquire continuation vehicle stakes should target dedicated secondary market platforms that specialize in GP-led transactions and continuation vehicles.

Methodology

This research guide covers private equity and venture capital firms selected based on verified AUM data, documented deal history, and strategy breadth as of early 2026. AUM figures come from fund performance databases, alternatives data providers, and firm-level disclosures. Market data reflects the 2024 full-year PE recovery period, including deal value and exit activity trends from global industry reporting and a 2024 academic literature review on private equity economics covering the $3 trillion asset class.

Researchers focused on lower-middle-market and emerging managers should consult alternatives data platforms and fund performance databases. These sources provide full coverage of the segment where the majority of investable fund opportunities by count reside.